Huiyu Li
Taiyuan, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 17 publications
Immune microenvironment evolution across the serrated neoplasia pathway and its relevance to immunotherapy.
Journal: Frontiers in oncology
Published: March 14, 2026
Research Progress on Tumor-Associated Macrophages and PD-1/PD-L1 Inhibitors in Advanced Colorectal Cancer.
Journal: Cancer control : journal of the Moffitt Cancer Center
Published: March 02, 2026
Identification and validation of Kif15 as a potential diagnostic and prognostic biomarker in colon cancer.
Journal: BMC gastroenterology
Published: July 31, 2025
The current status and prospects of gut microbiota combined with PD-1/PD-L1 inhibitors in the treatment of colorectal cancer: a review.
Journal: BMC gastroenterology
Published: December 24, 2024
Identification of CircRNAs that promote cancer and their potential contribution to hepatocellular carcinoma (HCC) pathogenesis.
Journal: Clinical and experimental medicine
Published: November 29, 2024
Preoperative inflammatory markers and tumor markers in predicting lymphatic metastasis and postoperative complications in colorectal cancer: a retrospective study.
Journal: BMC surgery
Published: November 25, 2024
FBXW7 metabolic reprogramming inhibits the development of colon cancer by down-regulating the activity of arginine/mToR pathways.
Journal: PloS one
Published: August 26, 2024
Progress, challenges, and future perspectives of robot-assisted natural orifice specimen extraction surgery for colorectal cancer: a review.
Journal: BMC surgery
Published: June 20, 2024
PD-1/PD-L1 inhibitors for early and middle stage microsatellite high-instability and stable colorectal cancer: a review.
Journal: International journal of colorectal disease
Published: May 22, 2024
Short-term and long-term efficacy in robot-assisted treatment for mid and low rectal cancer: a systematic review and meta-analysis.
Journal: International journal of colorectal disease
Published: December 06, 2023
Serine-arginine splicing factor 2 promotes oesophageal cancer progression by regulating alternative splicing of interferon regulatory factor 3.
Journal: RNA biology
Published: June 19, 2023
Last Updated: 09/26/2026